Evidence map›Paper›PMID 42283323›Full record

ArticleBiology open2026

Histone and non-histone protein acetylation in a tail regeneration model (Ambystoma mexicanum).

Nataliya Timoshevskaya, Raissa F Cecil, James Schwartz, Jeramiah J Smith, S Randal Voss

Abstract read
In one paragraph

Article in Biology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nataliya TimoshevskayaDepartment of Neuroscience, Spinal Cord and Brain Injury Research Center, and Ambystoma Genetic Stock Center, University of Kentucky, Lexington, KY 40536, USA.
Raissa F CecilDepartment of Neuroscience, Spinal Cord and Brain Injury Research Center, and Ambystoma Genetic Stock Center, University of Kentucky, Lexington, KY 40536, USA.
James SchwartzDepartment of Neuroscience, Spinal Cord and Brain Injury Research Center, and Ambystoma Genetic Stock Center, University of Kentucky, Lexington, KY 40536, USA.
Jeramiah J SmithDepartment of Biology, University of Kentucky, Lexington, KY 40506, USA.
S Randal VossDepartment of Neuroscience, Spinal Cord and Brain Injury Research Center, and Ambystoma Genetic Stock Center, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0002-8332-3176

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Jennifer F Rogers · 2013 to 2026
$38.3M
Ambystoma Genetic Stock Center - Revision to Include Curation and Informatics ComponentP40OD019794 · OD · UNIVERSITY OF KENTUCKY · PI Stephen Randal Voss · 2015 to 2026
$6.3M
Research Resources for Model AmphibiansR24OD010435 · OD · UNIVERSITY OF KENTUCKY · PI SMITH, JERAMIAH JAMES, VOSS, STEPHEN RANDAL · 2012 to 2025
$5.7M
NCI NIH HHS P30 CA177558NIH HHS OD010435NIH HHS OD019794NIH HHS P40 OD019794NIH HHS R24 OD010435University of Kentucky
6 · The paper itself

Abstract

Histone deacetylase inhibitors (HDACi) potently inhibit appendage regeneration, but how HDACi alter protein acetylation is relatively unexplored. Using genomic, transcriptomic, and proteomic approaches, we report HDACi-mediated changes in gene expression and protein acetylation at the outset of Ambystoma mexicanum tail regeneration. HDACi (romidepsin) treatment globally reversed a genome-wide deacetylation response after tail amputation, broadly increasing H3K9ac and H3K27ac within intergenic regions, gene promoters, and gene bodies. Changes in promoter acetylation were only weakly associated with changes in gene expression when considering all acetylated genes. However, the magnitude of acetylation change was significantly greater for upregulated genes, including previously identified regeneration-inhibitory genes. We further detected hundreds of differentially acetylated non-histone proteins after tail amputation, including proteins that function in transcriptional regulation and hemostasis. We used a small molecule (A-485) to inhibit differentially acetylated transcription factors (Crebbp/Ep300) to show their requirement for tail regeneration. A-485 downregulated many of the same genes that were downregulated by romidepsin, but the upregulated gene set was relatively unique. Our results implicated histone and non-histone protein acetylation in the early transcriptional regulation of regeneration associated genes.

Indexed as

Ambystoma mexicanumHistonesProtein Processing, Post-TranslationalRegenerationTailAcetylationAnimalsGene Expression ProfilingGene Expression RegulationHistone Deacetylase InhibitorsProteomicsHistone Deacetylase InhibitorsHistonesAcetylationAxolotlHDACHDACiNon-histone proteinRegenerationTranscription

Identifiers

PMID42283323
PMCPMC13446560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.